Important: VAERS reports alone cannot determine if a vaccine caused an adverse event. Reports may contain incomplete, inaccurate, or unverified information. Correlation does not equal causation.
#817 most reported symptom for this vaccine
Conjunctival hyperaemia has been reported 20 times in association with Measles, Mumps & Rubella (MMR II) vaccination in VAERS. This represents 0.0% of all 89,976 reports for this vaccine.
Among these reports, 1 mentioned death (5.00%) and 2 involved hospitalization (10.0%).
Conjunctival hyperaemia is the #817 most frequently reported symptom for Measles, Mumps & Rubella (MMR II) out of 2292 total symptoms.
Disclaimer: VAERS reports describe events that occurred after vaccination but do not establish that the vaccine caused the event. Many reported symptoms may be coincidental or related to underlying conditions.
Seeing 20 reports of Conjunctival hyperaemia after Measles, Mumps & Rubella (MMR II) vaccination may seem alarming, but context is critical.
The 5.00% mortality rate among these reports is elevated, but this reflects the severity of the condition itself rather than vaccine causation.
This data comes from the Vaccine Adverse Event Reporting System (VAERS), jointly managed by CDC and FDA.